Barriers and facilitators for screening and treatment of hyperlipidemia among patients with inflammatory arthritis

BACKGROUND: Patients with inflammatory arthritis (IA), defined as rheumatoid arthritis (RA) and psoriatic arthritis (PsA), are at increased risk for cardiovascular disease (CVD). The frequency of screening and treatment of hyperlipidemia, a modifiable CVD risk factor, is low in these patients. The r...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro-Millán, Iris, Young, Sarah R., Shurbaji, Sally, McDavid, Chastity, Cornelius-Schecter, Anna, Johnson, Bernadette, Cherrington, Andrea L., Fraenkel, Liana, Goodman, Susan M., Curtis, Jeffrey R., Venkatachalam, Shilpa, Safford, Monika M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265623/
https://www.ncbi.nlm.nih.gov/pubmed/32514493
http://dx.doi.org/10.1186/s41927-020-00123-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265623/
https://www.ncbi.nlm.nih.gov/pubmed/32514493
http://dx.doi.org/10.1186/s41927-020-00123-w

Ejemplares similares